Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Wednesday’s Top Upgrades (and Downgrades): WellPoint, Inc. (WLP) and Fossil, Inc. (FOSL)

Page 1 of 2

This series, brought to you by Yahoo! Finance, looks at which upgrades and downgrades make sense, and which ones investors should act on. Today, our headlines include a pair of downgrades for WellPoint, Inc. (NYSE:WLP) and Fossil, Inc. (NASDAQ:FOSL). On the plus side, though, one analyst thinks that …

Norwegian Cruise Line is bound for richer shores
The day begins on a bright note for shareholders of cruise ship operator Norwegian Cruise Line Holdings Ltd (NASDAQ:NCLH), which this morning received a price target hike — and a reiteration of its “buy” rating — from ace analyst Stifel Nicolaus.

WellPoint, Inc. (NYSE:WLP)

Norwegian reported strong earnings earlier this week, reporting on Monday that its Q4 earnings per share were $0.04 — four times higher than the Street consensus of just a penny-a-share. Revenues came in a bit light, granted ($503 million versus the estimated $513 million). On the other hand, Norwegian said it’s likely to earn no less than $0.02 per share this current quarter, and perhaps as much as a full nickel — either of which result would easily trounce analysts’ estimate of a penny-a-share loss. This news prompted won Norwegian an upgrade to “buy” from Nomura Securities yesterday, and today Stifel’s also doubling down on the stock. But if you ask me, that’s a mistake.

Why? Simple: The stock costs too much.

Consider: With $0.94 a share in 2012 profit, Norwegian now costs a bit more than 30 times trailing earnings. If the company can maintain the 32% profits growth rate it showed in 2012, that might look attractive — but 30%-plus growth rates are dreadfully hard to maintain over long periods of time.

Plus, Norwegian’s P/E ratio of 30 doesn’t factor in the company’s nearly $3 billion net debt. It doesn’t consider the fact that Norwegian’s real free cash flow is just $95 million — just 56% of reported net income. Valued on enterprise value and free cash flow, rather than market cap and earnings, Norwegian actually looks very expensive indeed, at an EV/FCF ratio of 90. It’s so expensive, indeed, that even if the company could grow at 30% a year for the next five years, I’d say this stock is still overpriced.

Fossil should be buried
Speaking of overpriced stocks, a couple days ago we took a look at the downgrade Benchmark Capital assigned to Fossil ahead of Q4 earnings. Now that Fossil’s numbers are out — $948 million in quarterly revenue, and earnings of $2.51 per share — Fossil’s catching another downgrade today (to underperform) from the folks at FBR Capital.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!